EHA joins forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 19th Annual Sickle Cell & Thalassaemia Conference.

Dates: October 2-5, 2024
Location: London, United Kingdom
Format: Physical only

The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.

Abstract submission

Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers as an oral presentation or poster.

Please select the most appropriate topic during the abstract & case submission:

  1. Basic and translational

  2. Novel therapies, gene therapies, bone marrow transplant and emerging diagnostics

  3. Clinical and epidemiological studies

  4. Infection, autoimmunity, nutritional deficiencies

  5. Ageing and end organ damage

  6. Health services and outcomes research including psychology

Abstract submission closed

Date Deadline
March 15, 2024 Start abstract & case submission
June 16, 2024 Deadline abstract & case submission
July 1, 2024 Notification of allocation to authors

For any questions regarding the abstract submission process, please contact

Target audience

Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields


The meeting will take place in County Hall, Westminster Bridge, London, United Kingdom.

For more information, click here.


The registration is open, for more info and to register click here


The program has not been released yet, but once available it will be published here.

EHA Topics-in-Focus Hemoglobinopathies

This meeting is part of the EHA Topics-in-Focus (TIF) program on Hemoglobinopathies, aimed at raising awareness, providing education, furthering research, and building a network of experts to improve patient care. Further information, please see our website.